Table 2 Treatment and outcome of valve IE patients

Cardiac surgery performed

63 (70)

31 (69)

32 (71)

0.82

Indication for surgery

 Heart failure

25 (40)

12 (39)

13 (41)

0.88

 Uncontrolled infection

22 (35)

11 (36)

11 (34)

0.93

 Prevention of embolic event

14 (22)

7 (23)

7 (22)

0.95

 Other

2 (3)

1 (3)

1 (3)

0.98

Type of surgery performed

 AVR

26 (41)

11 (36)

15 (47)

0.36

 MVR

13 (21)

7 (23)

6 (19)

0.71

 AVR and MVR

4 (6)

2 (7)

2 (6)

0.97

 Bentall / biological composite graft

15 (24)

10 (32)

5 (16)

0.12

 Other

5 (8)

1 (3)

4 (9)

0.17

Timing of surgery

Indication

  Emergent

0

0

0

–

 Urgent

56 (89)

28 (90)

28 (88)

0.72

 Urgent/elective

1 (2)

0

1 (3)

0.32

 Elective

6 (10)

3 (10)

3 (9)

0.97

Urgent surgery

Time from urgent indication to surgery, days

5 (2–8)

4 (2–8)

6 (2–8)

0.82

Surgery within 24 h after indication

9 (16)

4 (14)

5 (18)

0.72

Surgery within 1 to 3 days after indication

11 (20)

6 (21)

5 (18)

0.74

Surgery within 4 to 7 days after indication

19 (40)

10 (36)

9 (32)

0.59

Surgery 7 or more days after indication

17 (30)

8 (29)

9 (32)

0.77

In hospital complications

54 (60)

24 (53)

30 (67)

0.20

Embolic event

28 (31)

12 (27)

16 (36)

0.81

Acute heart failure

14 (16)

5 (11)

9 (20)

0.45

Cardiac shock

4 (4)

1 (2)

3 (7)

0.42

Intracranial hemorrhage

5 (6)

0

5 (11)

0.04

Renal failure

21 (23)

12 (27)

9 (20)

0.13

Deceased during hospitalization

5 (6)

2 (4)

3 (7)

0.65

Follow-up

Readmission after initial discharge

17 (19)

7 (16)

10 (22)

0.42

Relapse or re-infection

5 (6)

2 (4)

3 (7)

0.65

Thoracic surgery after initial discharge

8 (9)

4 (9)

4 (9)

1.0

Deceased within 6 months after diagnosis

11 (12)

5 (11)

6 (13)

0.75

Discharge

Duration of hospital admission (days)

17 (11–34)

17 (10–34)

19 (11–34)

0.97